Andrew Sinclair, Director at SOLENO THERAPEUTICS INC (SLNO), bought 6,666,660 shares at $1.65 ($11.0M) on 2020-06-26, disclosed to the SEC on 2020-07-06.
Open-market purchase of $11.0M SLNO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 3,333,330 | $5.5M | 50.0% |
| 2 | $1.65 | 3,333,330 | $5.5M | 50.0% |
| Total | $1.65 avg | 6,666,660 | $11.0M | 100% |
| Filing → |
| SLNO | BUY | 2019-10-29 | $2.8M | — | Filing → |
| SLNO | BUY | 2018-12-27 | $14.9M | — | Filing → |